These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7658207)

  • 1. Transient hypothyroidism after iodine-131 therapy for Grave's disease.
    Gómez N; Gómez JM; Orti A; Gavaldà L; Villabona C; Leyes P; Soler J
    J Nucl Med; 1995 Sep; 36(9):1539-42. PubMed ID: 7658207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early development of transient hypothyroidism after I131 therapy for thyrotoxicosis.
    Khanna CM; Sankar R; Magdum M; Gera A
    J Assoc Physicians India; 1998 Mar; 46(3):268-72. PubMed ID: 11273344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of treatment of Graves-Basedow disease with 131I at low calculated doses].
    Gómez Arnaiz N; Gómez Saez JM; Orti Llavería A; Gavaldá Mestre L; Mairal Pairó L; Soler Ramón J
    Rev Clin Esp; 1998 Feb; 198(2):57-60. PubMed ID: 9558917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism and prognosis.
    Aizawa Y; Yoshida K; Kaise N; Fukazawa H; Kiso Y; Sayama N; Hori H; Abe K
    Clin Endocrinol (Oxf); 1997 Jan; 46(1):1-5. PubMed ID: 9059550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results following 131I treatment for Graves' disease in Hong Kong Chinese--discriminant factors predicting hypothyroidism.
    Kung AW; Pun KK; Lam KS; Choi P; Wang C; Yeung RT
    Q J Med; 1990 Sep; 76(281):961-7. PubMed ID: 2236479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simplified method for treating Graves' disease with radioactive 131I.
    Masri MT; Menne M; Rooney BL; Caplan RH
    Wis Med J; 1995 Jan; 94(1):21-5. PubMed ID: 7871797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological changes in 88 cases of Basedow's disease treated by radioactive iodine].
    Schrub JC; Nouel JP; Brunelle P; Segond G; Courtois H; Poirier A
    Nouv Presse Med; 1976 May; 5(21):1346-8. PubMed ID: 778789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up study of compensated low-dose 131I therapy for Graves' disease.
    Sridama V; McCormick M; Kaplan EL; Fauchet R; DeGroot LJ
    N Engl J Med; 1984 Aug; 311(7):426-32. PubMed ID: 6205272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiotherapy with 131J and 125J of Basedow's disease. Indications and results relative to the incidence of post-actinic hypothyroidism].
    Dradi C; Riceputi G; Biagioli R; Riva P
    Minerva Med; 1979 Jan; 70(2):135-41. PubMed ID: 581903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient hypothyroidism after iodine-131 treatment of Graves' disease.
    Gómez JM; Virgili N; Soler J; Fernández M; Montaña E
    Thyroidology; 1989 Dec; 1(3):149-52. PubMed ID: 2484879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years' retrospective study.
    Ceccarelli C; Bencivelli W; Vitti P; Grasso L; Pinchera A
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):331-5. PubMed ID: 15730415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease].
    Sabri O; Schulz G; Zimny M; Schreckenberger M; Zimny D; Wagenknecht G; Kaiser HJ; Dohmen BM; Bares R; Büll U
    Nuklearmedizin; 1998 May; 37(3):83-9. PubMed ID: 9604227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?
    Dietlein M; Moka D; Reinholz U; Schmidt M; Schomäcker K; Schicha H; Wellner U
    Nuklearmedizin; 2007; 46(3):77-84. PubMed ID: 17549318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of Graves-Basedow's disease with 131I. Assessment of a "modulated fixed activity" protocol].
    Abós D; Ruiz P; Prats E; Razola P; García F; Tardín L; Banzo J
    Rev Esp Med Nucl; 2007; 26(1):3-10. PubMed ID: 17286943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Late results of treating thyrotoxicosis with 131I and post-therapeutic hypothyroidism].
    Khelds AO; Ozols VK; Shtelmane IA
    Med Radiol (Mosk); 1986 Mar; 31(3):24-7. PubMed ID: 2421127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.